FDA.reportPublic FDA data

SenokotXTRA 17.2 MG Oral Tablet

RxCUI
1039965
RxNorm name
SenokotXTRA 17.2 MG Oral Tablet
Display name
SenokotXTRA 17.2 MG Oral Tablet
Full name
SenokotXTRA 17.2 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SenokotSTANDARDIZED SENNA CONCENTRATEAtlantis Consumer Healthcare, Inc.d5bf67e5-82c6-edbf-e9ec-e027fdd47c842025-08-20WarningsExact identifier
rxcui: 1039965

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d5bf67e5-82c6-edbf-e9ec-e027fdd47c84SenokotXTRA 17.2 MG Oral Tablet [PSN] · sennosides, USP 17.2 MG Oral Tablet [Senokot] [SBD] · Senokot 17.2 MG Oral Tablet [SY] · SenokotXTRA 17.2 MG Oral Tablet [SY]411SenokotXTRA (standardizedsenna concentrate) Drug Facts20250820